Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, AstraZeneca Pharma India has informed that Pankaj Jain, currently the Head – Legal at the Company has decided to pursue his career outside the organization. He will complete his handover period by close of business hours on October 31, 2025. The Company is looking for a suitable replacement for the said position. The information as required under the SEBI circular SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023, along-with a copy of the resignation letter is enclosed.
The above information is a part of company’s filings submitted to BSE.